Declan's post | Quora

How Covid Vaccines & FDA Decisions Shook Up the Financial World 🌍💸 Okay, real talk: remember that wild ride back in 2020 when every news alert was about covid vaccines and the FDA? I still remember sitting at my desk, coffee in hand, watching the stock ticker bounce like a yo-yo. I mean, who else got obsessed with every FDA press conference? If you were in the markets, you know exactly what I’m talking about! From Lab Bench to Wall Street: The Vaccine Rally So here’s the thing: when the world was holding its breath for a covid vaccine, Wall Street was too. Every time Pfizer, Moderna, or Johnson & Johnson dropped a press release, stocks surged—or tanked. I remember that day in November 2020, when Pfizer announced their vaccine was over 90% effective (pending FDA approval, of course). The market went crazy! Airlines, hotels, restaurants—all those beaten-down “reopening” stocks shot through the roof. On the flip side, all those “stay-at-home” winners—think Zoom, Peloton—suddenly weren’t so cool anymore. Their stocks took a breather, and it was almost like you could feel the collective FOMO and panic coming through your trading app. Honestly, I’d never seen such quick rotations before. It turned out, the FDA’s vaccine decisions weren’t just about public health—they were massive market catalysts. How FDA Approval = Financial Green Light Here’s what I realized: FDA approval isn’t just a science thing, it’s a financial launchpad. Before approval, it’s all hype and hope. After approval? That’s when the serious institutional money moves in. Remember the day Moderna got their Emergency Use Authorization? Suddenly, everyone from hedge funds to your cousin’s crypto group chat was talking about vaccine stocks. But it wasn’t just the vaccine makers. The ripple effect touched healthcare ETFs, medical supply chains, even insurance companies. And let’s not forget the wild volatility! I definitely got caught in a few whiplash trades—one day you’re up 15%, next day you’re wondering why you didn’t just invest in index funds and chill. The Financial Lessons (I Wish I Knew Sooner!) Timing the market around FDA news is basically gambling. Even the pros get it wrong! Diversification matters more than ever. I watched friends go all-in on “the next vaccine winner” and, well… let’s just say it wasn’t always pretty. Sentiment and headlines drive short-term moves, but fundamentals win in the long run. The hype fades, but companies with real pipelines and profits stick around. My Personal Take: Stay Informed, Stay Sane Looking back, those months taught me more about financial markets than any business class ever could. The intersection of covid vaccines & FDA decisions was a masterclass in how science, policy, and finance collide. Sure, it was stressful, but it was also kind of thrilling to see how fast things could change. If I had to give advice to my past self (or anyone new to investing)? Don’t chase headlines—understand the bigger picture. FDA approvals will always be big market movers, but hype fades and fundamentals matter. And if you’re gonna play the biotech game, buckle up for a wild ride! What about you? Did the covid vaccine news make you rethink your financial strategy? Did you ride the vaccine stock rollercoaster, or sit it out? Drop your stories and lessons below—let’s learn from each other! Because if there’s one thing this whole saga taught me, it’s that finance isn’t just about numbers. It’s about people, emotions, and those split-second decisions that can change everything.